MS

Genzyme sees MS drug topping efficacy league
Reuters
Wed, 04/14/10 - 01:59 pm
Genzyme
Campath
multiple sclerosis
MS
Acorda’s Ampyra Runs Ahead of Other MS Treatments
Minyanville
Wed, 04/14/10 - 01:56 pm
MS
Acorda Therapeutics
AMPYRA
multiple sclerosis
Novartis moves closer to first oral MS treatment
Reuters
Tue, 04/13/10 - 09:58 am
Novartis
MS
multiple sclerosis
Gilenia
Biogen Races to Create Test for Brain Disease Linked to MS Drug
Bloomberg
Fri, 04/9/10 - 07:52 am
Biogen Idec
Tysabri
MS
multiple sclerosis
PML
Biogen, Merck, Bayer MS Drugs Targeted by Test Predicting Which Ones Work
Bloomberg
Mon, 03/29/10 - 10:09 am
Biogen Idec
Merck
Bayer
MS
multiple sclerosis
Acorda applies to extend Ampyra patent protection
Yahoo/AP
Mon, 03/22/10 - 09:54 am
Acorda Therapeutics
patents
AMPYRA
MS
multiple sclerosis
Biogen: Now 42 Cases Of Brain Infection In Tysabri Patients
WSJ Online
Thu, 03/18/10 - 07:28 am
Biogen Idec
Elan
Tysabri
MS
PML
Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
WSJ Online
Wed, 02/17/10 - 09:01 am
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Teva, Active extend pact on oral MS therapy
Marketwatch
Mon, 02/8/10 - 11:37 am
Teva Pharmaceuticals
Active Biotech
partnerships
MS
multiple sclerosis
Acorda's MS Drug May Not Be the Windfall Investors Expect
Seeking Alpha
Wed, 01/27/10 - 10:57 am
Acorda Therapeutics
MS
multiple sclerosis
Biogen Idec
AMPYRA
FDA approves Biogen Idec multiple sclerosis treatment Ampyra
Bizjournals.com
Mon, 01/25/10 - 12:36 pm
MS
multiple sclerosis
Biogen Idec
FDA
AMPYRA
Novartis, Merck KGaA Pills Bring ‘New Horizon’ for MS
Bloomberg
Thu, 01/21/10 - 09:01 am
MS
multiple sclerosis
Novartis
Merck KGaA
Biogen Idec says Tysabri sales top $1 billion, new patients grow 30 percent
Yahoo/AP
Wed, 01/13/10 - 09:22 am
Biogen Idec
Tysabri
MS
multiple sclerosis
Can Novartis Win Race to Launch First Oral Drug for MS?
BNET Pharma
Fri, 12/4/09 - 08:38 am
MS
multiple sclerosis
Novartis
Merck KGaA
Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
BNET Pharma
Fri, 11/13/09 - 08:55 am
Biogen Idec
social media
FDA
Tysabri
MS
multiple sclerosis
Avanir shares jump on new Zenvia data
Fierce Biotech
Wed, 11/11/09 - 08:24 am
Zenvia
Avanir
MS
multiple sclerosis
Teva says it wants to add 3 more patents to suit against Moment and Sandoz over Copaxone
Yahoo/AP
Tue, 11/10/09 - 09:59 am
Teva Pharmaceuticals
Sandoz
Copaxone
Momenta
lawsuits
MS
multiple sclerosis
Elan, Biogen change Tysabri label due to PML risk
Reuters
Mon, 11/9/09 - 10:07 am
Elan
Biogen Idec
Tysabri
PML
MS
More PML Troubles for Biogen, Elan MS Drug
TheStreet.com
Thu, 10/29/09 - 10:28 am
Biogen Idec
Elan
PML
Tysabri
MS
multiple sclerosis
Reviving Tysabri
Forbes
Tue, 10/27/09 - 04:32 pm
Tysabri
Elan
Biogen Idec
MS
multiple sclerosis

Pages